Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-08-12 06:44 am Purchase |
2022-06-16 | 13D | Wave Life Sciences Ltd. WVE |
Shin Nippon Biomedical Laboratories Ltd. | 9,666,408 10.600% |
3,771,930 (+63.99%) |
Filing History |
| 2022-07-20 06:08 am Sale |
2020-09-22 | 13D | Wave Life Sciences Ltd. WVE |
Kagoshima Shinsangyo Sousei Investment Limited Partnership | 2,019,873 3.300% |
-115,101 (-5.39%) |
Filing History |
| 2022-06-21 4:35 pm Purchase |
2009-02-28 | 13D | Wave Life Sciences Ltd. WVE |
RA Capital Management, L.P. | 17,269,811 19.990% |
9,441,354 (+120.60%) |
Filing History |
| 2022-05-26 4:44 pm Purchase |
2022-05-16 | 13G | Wave Life Sciences Ltd. WVE |
683 Capital Management, LLC | 3,630,425 5.900% |
3,630,425 (New Position) |
Filing History |
| 2022-02-14 3:07 pm Purchase |
2021-12-31 | 13G | Wave Life Sciences Ltd. WVE |
MAVERICK CAPITAL LTD | 5,593,389 9.500% |
5,593,389 (New Position) |
Filing History |
| 2022-02-14 08:27 am Sale |
2021-12-31 | 13G | Wave Life Sciences Ltd. WVE |
Nantahala Capital Management, LLC | 907,094 1.500% |
-2,450,211 (-72.98%) |
Filing History |
| 2022-02-11 4:42 pm Purchase |
2021-12-31 | 13G | Wave Life Sciences Ltd. WVE |
BB BIOTECH AG | 4,602,858 7.800% |
2,000,000 (+76.84%) |
Filing History |
| 2022-02-11 4:18 pm Sale |
2021-12-31 | 13G | Wave Life Sciences Ltd. WVE |
Flynn James E | 552,690 0.940% |
-3,357,740 (-85.87%) |
Filing History |
| 2022-02-11 4:06 pm Unchanged |
2021-12-31 | 13G | Wave Life Sciences Ltd. WVE |
PFIZER INC PFE |
1,875,000 3.190% |
0 (Unchanged) |
Filing History |
| 2022-02-10 12:29 pm Purchase |
2021-12-31 | 13G | Wave Life Sciences Ltd. WVE |
PRIMECAP MANAGEMENT CO | 4,594,575 7.810% |
670,100 (+17.07%) |
Filing History |
| 2021-12-10 10:05 am Sale |
2021-11-30 | 13G | Wave Life Sciences Ltd. WVE |
BLACKROCK INC BLK |
2,863,620 4.900% |
-161,584 (-5.34%) |
Filing |
| 2021-11-12 4:30 pm Purchase |
2009-02-28 | 13D | Wave Life Sciences Ltd. WVE |
RA Capital Management, L.P. | 7,828,457 13.300% |
5,250 (+0.07%) |
Filing History |
| 2021-10-29 11:37 am Purchase |
2021-10-27 | 13G | Wave Life Sciences Ltd. WVE |
M28 Capital Management LP | 3,765,588 7.200% |
3,765,588 (New Position) |
Filing History |
| 2021-08-18 5:30 pm Purchase |
2009-02-28 | 13D | Wave Life Sciences Ltd. WVE |
RA Capital Management, L.P. | 7,823,207 15.390% |
48,000 (+0.62%) |
Filing History |
| 2021-04-09 1:19 pm Purchase |
2021-03-30 | 13G | Wave Life Sciences Ltd. WVE |
Flynn James E | 3,910,430 7.980% |
3,910,430 (New Position) |
Filing History |
| 2021-02-16 4:09 pm Sale |
2020-12-31 | 13G | Wave Life Sciences Ltd. WVE |
Redmile Group LLC | 79,018 0.200% |
-3,247,475 (-97.62%) |
Filing History |
| 2021-02-16 10:23 am Purchase |
2020-12-31 | 13G | Wave Life Sciences Ltd. WVE |
Nantahala Capital Management, LLC | 3,357,305 6.900% |
3,357,305 (New Position) |
Filing History |
| 2021-02-12 4:48 pm Purchase |
2020-12-31 | 13G | Wave Life Sciences Ltd. WVE |
BB BIOTECH AG | 2,602,858 5.300% |
200,000 (+8.32%) |
Filing History |
| 2021-02-12 12:02 pm Purchase |
2009-02-28 | 13G | Wave Life Sciences Ltd. WVE |
PRIMECAP MANAGEMENT CO | 3,924,475 8.050% |
3,924,475 (New Position) |
Filing History |
| 2021-02-12 11:35 am Sale |
2020-12-31 | 13G | Wave Life Sciences Ltd. WVE |
MORGAN STANLEY MS |
1,245,226 2.600% |
-703,006 (-36.08%) |
Filing History |